Jackson Syndrome

Jackson Syndrome
Other Names	Vagal-Accessory-Hypoglossal Syndrome, Hughlings Jackson Syndrome
Identifiers
ICD-9	352.6
ICD-10	G52.7

1. Jackson Syndrome

Overview

Jackson syndrome is a rare medullary (brainstem) syndrome characterized by dysfunction of cranial nerve X (vagus), cranial nerve XI (accessory), and cranial nerve XII (hypoglossal), resulting from lesions affecting the nucleus ambiguus and hypoglossal nucleus region in the ventrolateral medulla oblongata.

The syndrome produces ipsilateral paralysis of the soft palate, larynx, sternocleidomastoid, trapezius, and tongue.

Critical anatomical distinction: Jackson syndrome is specifically a central (medullary) syndrome, distinguishing it from the peripheral skull base syndromes (Vernet, Collet-Sicard, Villaret) which involve the same cranial nerves but at different anatomical locations (jugular foramen, hypoglossal canal, retroparotid space). This distinction has critical prognostic implications: peripheral cranial nerve palsies mostly resolve completely over time, while central palsies from brainstem stroke typically do not.

History

John Hughlings Jackson (1835-1911) was one of the founding fathers of British neurology and worked primarily at the National Hospital for the Paralysed and Epileptic at Queen Square, London. He made seminal contributions to understanding epilepsy, aphasia, and the hierarchical organization of the nervous system.

Jackson first reported the syndrome in 1864, and described a further case caused by medullary hemorrhage in 1872 with hypoglossal nerve palsy and incomplete vagal paresis. His work was part of a broader 19th-century effort to map brainstem syndromes to specific anatomical locations. Other medullary syndromes described during this era include Wallenberg syndrome (lateral medullary), Dejerine syndrome (medial medullary), and Avellis syndrome (vagus and spinothalamic tract).

Pathophysiology

Relevant Anatomy

Medullary nuclei involved:

Nucleus ambiguus:

• Motor nucleus for cranial nerve IX, cranial nerve X, cranial nerve XI (cranial portion)
• Located in ventrolateral medulla
• Provides motor innervation to:
  • Pharyngeal constrictors
  • Soft palate (levator veli palatini)
  • Laryngeal muscles (via recurrent laryngeal nerve)
  • Upper esophagus

Hypoglossal nucleus:

• Located in dorsomedial medulla near floor of fourth ventricle
• Provides motor innervation to all intrinsic and most extrinsic tongue muscles
• Forms hypoglossal triangle in floor of fourth ventricle
• Hypoglossal involvement is a key distinguishing feature separating hemimedullary (Reinhold) syndrome from Babinski-Nageotte syndrome

Spinal accessory nucleus:

• Extends from C1-C5 spinal segments
• Cranial portion contributes to cranial nerve XI
• Innervates sternocleidomastoid muscle and trapezius

Vascular supply:

• Anterior spinal artery: Supplies medial medulla including hypoglossal nucleus
• Posterior inferior cerebellar artery (PICA): Supplies lateral medulla
• Vertebral artery: Direct branches to ventral medulla

Disease Etiology

Causes of Jackson syndrome:

Vascular (most common):

• Vertebral artery occlusion or dissection
• Anterior spinal artery occlusion
• Brainstem infarction
• Hemorrhage

Internal carotid artery dissection (important underrecognized cause):

• Cranial nerve palsy occurs in approximately 10% of spontaneous cervical artery dissections
• Mechanism differs by dissection type:
  • Steno-occlusive dissections (proximal ICA): Cause CN II, III, VII palsies via hypoperfusion/microembolism
  • Expansive dissections (distal ICA): Cause CN IX, X, XI, XII palsies via local mass effect from pseudoaneurysm formation
• Critical clinical point: Peripheral palsies from dissection mostly resolve completely; central palsies from brainstem stroke do not—making cerebrovascular imaging essential for prognosis

COVID-19/ICU-related (emerging cause):

• 11% of ICU patients (10/88) developed lower cranial nerve palsies after severe COVID-19
• Hypoglossal nerve palsy most common (9/10 patients)
• Mechanism: Mechanical compression from prone-position ventilation therapy
• Most patients recovered within one month

Neoplastic:

• Brainstem glioma
• Metastatic disease
• Meningioma of foramen magnum
• Skull base tumors (chordoma, chondrosarcoma)
• Jugular foramen tumors

Demyelinating:

• Multiple sclerosis
• Acute disseminated encephalomyelitis (ADEM)

Infectious/Inflammatory:

• Brainstem encephalitis
• Tuberculosis
• Sarcoidosis
• Neurosyphilis

Traumatic:

• Skull base fractures (atlas or condylar fractures)
• Penetrating trauma

Congenital:

• Arnold-Chiari malformation
• Syringobulbia

Genetics

No genetic predisposition specific to Jackson syndrome; underlying conditions (e.g., connective tissue disorders predisposing to dissection, familial tumor syndromes) may have genetic components.

Histology

Histological findings depend on etiology:

• Vascular: Infarction, gliosis, neuronal loss in affected nuclei
• Neoplastic: Tumor-specific histology
• Demyelinating: Demyelinated plaques, inflammation

Diagnosis

Patient History

Presenting symptoms reflect involvement of CN X, XI, and XII:

Swallowing difficulties (dysphagia):

• Difficulty with bolus control
• Nasal regurgitation
• Aspiration
• Coughing/choking with meals

Voice changes:

• Hoarseness or breathy voice
• Diplophonia
• Reduced vocal projection

Speech difficulties (dysarthria):

• Slurred speech
• Difficulty with lingual consonants
• Nasal speech quality

Neck/shoulder weakness:

• Difficulty turning head
• Shoulder drop
• Arm elevation weakness

Associated symptoms (depending on lesion extent):

• Headache (if vascular or mass lesion)
• Vertigo
• Ataxia
• Contralateral sensory loss (if long tracts involved)

Physical Examination

Cranial nerve X examination:

• Palate: Ipsilateral palate droop, uvula deviation to contralateral side
• Gag reflex: Diminished on affected side
• Voice: Hoarseness, breathiness

Cranial nerve XI examination:

• Sternocleidomastoid: Weakness turning head to contralateral side
• Trapezius: Shoulder droop, weakness of shoulder shrug
• Atrophy may be present in chronic cases

Cranial nerve XII examination:

• Tongue at rest: May show fasciculations (LMN lesion)
• Tongue protrusion: Deviates toward affected side
• Tongue bulk: Ipsilateral atrophy in chronic cases
• Difficulty with rapid alternating tongue movements

Laryngoscopy findings:

• Ipsilateral vocal fold paralysis
• Pooling of secretions
• Reduced palatal elevation

Laboratory Tests

Laboratory evaluation focuses on underlying etiology:

• Complete blood count: Infection, malignancy
• ESR/CRP: Inflammatory conditions
• Glucose, lipid panel: Vascular risk factors
• Coagulation studies: Hypercoagulable states
• ANA, ANCA: Vasculitis screen
• Lumbar puncture: If infection, inflammation, or demyelination suspected

Imaging: 2022 ACR Appropriateness Criteria

ACR Appropriateness Criteria (2022) provide detailed recommendations for multiple lower cranial nerve palsies:

MRI head with contrast (preferred initial imaging):

• Indications: Evaluating posterior skull base pathology, posterior fossa lesions, brainstem pathology, leptomeningeal processes
• Sequences:
  • DWI/ADC: Essential for acute brainstem infarction detection (though false-negatives can occur with very small brainstem infarcts)
  • T1 pre/post-contrast: Mass lesions, enhancement patterns
  • T2/FLAIR: Demyelination, edema
  • GRE/SWI: Hemorrhage detection

Advanced MRI techniques:

• Thin-cut heavily T2-weighted contrast-enhanced modified balanced SSFP sequences: Provide detailed imaging of lower cranial nerves within the jugular foramen, with 90-100% of CN IX, X, and XII visible
• Contrast-enhanced MRA: Evaluates relationship of nerves to vascular structures

CTA head and neck:

• Indication: When internal carotid artery dissection is clinically suspected
• Sensitivity: 66% for blunt carotid vascular injury (most false negatives are low-grade injuries)
• T1-weighted axial cervical MRI with fat-saturation provides highest sensitivity and specificity for dissection

Important imaging consideration: Complete evaluation of CN IX, XI, and XII requires head and neck imaging since these nerves extend into the neck. For CN X, evaluation of the head, neck, and upper chest (to the aortopulmonary window) is necessary to include the recurrent laryngeal nerve.

Differential Diagnosis

There are several named syndromes differentiating the various cranial nerve deficits that can result from skull base masses and lesions. These should be considered based on cranial nerve involvement.

• Vernet Syndrome
• Collet-Sicard Syndrome
• Villaret Syndrome
• Tapia Syndrome
• Schmidt Syndrome

These syndromes and their respective cranial nerve involvement are outlined in the table below.

Cranial Nerve Involvement in Skull Base Masses

Syndrome	CN IX	CN X	CN XI	CN XII	Sympathetics
Vernet Syndrome	✔	✔	✔
Collet-Sicard Syndrome	✔	✔	✔	✔
Villaret Syndrome	✔	✔	✔	✔	✔
Tapia Syndrome		✔	±	✔	±
Jackson Syndrome		✔	✔	✔
Schmidt Syndrome		✔	✔

Comparison of Medullary Syndromes

Critical distinctions for medullary syndrome classification:

Syndrome	Cranial Nerves	Key Features	Lesion Location
Wallenberg (lateral medullary)	V, VIII, IX, X	Horner syndrome, ataxia, crossed sensory loss	Lateral medulla (PICA territory)
Dejerine (medial medullary)	XII	Contralateral hemiparesis, deep sensory loss	Medial medulla (ASA territory)
Jackson	X, XI, XII	No long tract signs	Ventrolateral medulla
Babinski-Nageotte	Wallenberg + contralateral hemiparesis	All Wallenberg features + pyramidal signs; NO hypoglossal palsy	Intermediolateral medulla
Hemimedullary (Reinhold)	XII + Wallenberg features	Hypoglossal palsy is invariable	Complete hemimedulla
Avellis	X	Spinothalamic involvement (crossed sensory loss)	Nucleus ambiguus + spinothalamic tract

Critical distinction: Babinski-Nageotte syndrome is NOT identical to hemimedullary syndrome—hypoglossal palsy is not part of Babinski-Nageotte syndrome but is invariable in hemimedullary (Reinhold) syndrome.

Management

Medical Management

Treatment focuses on underlying etiology and supportive care:

Etiologic treatment:

• Stroke: Antiplatelet therapy, statin, blood pressure management, stroke rehabilitation
• Dissection: Anticoagulation or antiplatelet therapy; surgical/endovascular intervention if indicated
• Demyelinating disease: Corticosteroids, disease-modifying therapy
• Infection: Appropriate antimicrobial therapy
• Vasculitis: Immunosuppression

Dysphagia Management: Evidence-Based Rehabilitation

Instrumental evaluation is essential:

• Videofluoroscopy or FEES is necessary to visualize swallow physiology and determine presence/absence of aspiration
• Bedside evaluation alone cannot predict aspiration—patients can aspirate without overt clinical signs

Behavioral therapy protocols with evidence (2024 Lancet Neurology review):

Chin-tuck against resistance (CTAR):

• Meta-analysis of 8 RCTs showed improvements in swallowing safety and oral intake
• More effective than Shaker exercises
• Decreased aspiration in patients with post-stroke dysphagia

Shaker exercises:

• Head-lifting exercise to increase laryngeal elevation and upper esophageal sphincter opening
• RCT showed improvement in penetration-aspiration scale

Expiratory muscle strength training (EMST):

• Reduces penetrations/aspirations and improves oral intake

Neurostimulation approaches:

• Transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS): Promising results for promoting neuroplasticity
• Pharyngeal electrical stimulation: Emerging evidence
• However, high-quality studies showing effects on pneumonia, functional outcome, or mortality are scarce

Timing of interventions:

• Acute phase: Focus on complication prevention; enteral nutrition via nasogastric tube if needed
• Post-acute/chronic phase: All dysphagia therapies including restitutive measures; PEG for chronic dysphagia

Aspiration risk stratification:

• Aspiration occurrence depends critically on lesion location
• Middle-level lesions, particularly those that are inferior-dorsolateral, are most strongly associated with aspiration

Voice Rehabilitation

• Speech therapy for dysarthria
• Vocal exercises
• Lee Silverman Voice Treatment (LSVT) for reduced loudness

Surgical Management

Surgical intervention depends on etiology:

Tumor resection:

• Skull base approaches for accessible lesions
• Debulking for non-resectable tumors

Vascular intervention:

• Vertebral artery stenting or bypass (select cases)
• Aneurysm treatment if present

Vocal fold medialization (for persistent vocal fold paralysis):

• Injection laryngoplasty (temporary or permanent)
• Thyroplasty type I

Palatal surgery:

• Palatal lift prosthesis
• Palatopharyngeal surgery (rarely indicated)

Outcomes

Complications

• Aspiration pneumonia: Major cause of morbidity
• Malnutrition/Dehydration: From dysphagia
• Communication disability: From dysarthria
• Reduced quality of life: Functional limitations
• Progression: Depends on underlying etiology

Prognosis

Critical prognostic distinction: Peripheral vs Central Palsies:

• Peripheral palsies (from dissection, compression): Mostly resolve completely over time
• Central palsies (from brainstem stroke): Do not typically resolve
• This distinction is critical for patient counseling

Post-stroke recovery patterns:

• Functional recovery generally completed within 3-5 months depending on severity
• Patients with mild stroke recover within 2 months
• Patients with severe stroke recover within 4-5 months
• Functional recovery is preceded by neurologic recovery by a mean of 2 weeks

Factors associated with better outcomes:

• Onset of symptoms <7 days: Adjusted OR 1.73 (95% CI 1.03-2.89) for good long-term outcome
• Isolated nerve involvement: Adjusted OR 2.56 (95% CI 1.21-5.39) for good outcome

Post-traumatic outcomes (Collet-Sicard syndrome as model):

• Atlas (C1) fractures: Better recovery (1 complete recovery, 4 significant improvement out of 5 cases)
• Condylar fractures: Poorer outcomes (3 unchanged, 6 modest improvement out of 9 cases)
• Conservative treatment (cervical immobilization) is the treatment of choice

COVID-19/ICU-related palsies:

• Most patients recovered within one month
• Better prognosis than stroke-related palsies

General principles:

• Early identification and treatment of cause improves outcomes
• Swallowing therapy and aspiration precautions reduce complications
• Multidisciplinary management essential

See Also

• Wallenberg Syndrome
• Dejerine Syndrome
• Vernet Syndrome
• Collet-Sicard Syndrome
• Villaret Syndrome
• Tapia Syndrome
• Schmidt Syndrome
• Jugular Foramen Syndrome